We have established that the Arf tumor suppressor gene regulates mural cell biology in the hyaloid vascular system (HVS) of the developing eye. In the absence of Arf, perivascular cells accumulate within the HVS and prevent its involution. We now demonstrate that mural cell accumulation evident at embryonic day (E) 13.5 in Arf(-/-) mice was driven by excess proliferation at E12.5, when Arf expression was detectable in vitreous pericyte-like cells. Their expression of Arf overlapped with Pdgf receptor beta (Pdgfrbeta), which is essential for pericyte accumulation in the mouse. In cultured cells, p19Arf decreased Pdgfrbeta and blocked Pdgf-B-driven proliferation independently of Mdm2 and p53. The presence of a normal Arf allele correlated with decreased Pdgfrbeta in the embryonic vitreous. Pdgfrbeta was required for vitreous cell accumulation in the absence of Arf. Our findings demonstrate a novel, p53- and Mdm2-independent function for p19Arf. Instead of solely sensing excessive mitogenic stimuli, developmental cues induce Arf to block Pdgfrbeta-dependent signals and prevent the accumulation of perivascular cells selectively in a vascular bed destined to regress.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1182246PMC
http://dx.doi.org/10.1038/sj.emboj.7600751DOI Listing

Publication Analysis

Top Keywords

perivascular cells
12
mural cell
8
absence arf
8
cell accumulation
8
decreased pdgfrbeta
8
arf
7
cells
5
arf-dependent regulation
4
regulation pdgf
4
pdgf signaling
4

Similar Publications

Biomarkers.

Alzheimers Dement

December 2024

Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA, USA.

Background: Glymphatic clearance dysfunction within the perivascular space has been implicated in Alzheimer's Disease (AD) pathology. Diffusion MRI-based techniques such as DTI-ALPS can quantify perivascular interstitial fluid (ISF) dynamics, yet their links with other early AD markers in the cognitively normal elderly population remain underexplored. Here, we investigated associations between DTI-ALPS and cerebral β-amyloid (Aβ) burden measured with Pittsburgh Compound B (PiB)-PET.

View Article and Find Full Text PDF

Biomarkers.

Alzheimers Dement

December 2024

University of California, Los Angeles, Los Angeles, CA, USA.

Background: Alzheimer's Disease and other neurodegenerative diseases are characterized by abnormal tau protein accumulation in the brain. PET imaging utilizing the [F-18]flortaucipir tracer is a widely used method for visualizing such conditions, yet its effectiveness can be compromised by off-target binding. To shed light on this issue, our study focuses on how elevated cholesterol concentrations of low-density lipoproteins (LDL) and standard uptake values (SUVR) from corresponding tau-PET scans may influence the efficacy of [F-18]flortaucipir.

View Article and Find Full Text PDF

Developing Topics.

Alzheimers Dement

December 2024

cheonan chungmu hospital, cheonan si, Korea, Republic of (South).

Background: Vascular contributions to dementia & Alzheimer's disease are increasing recognized. Recent studies have suggested that blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction, including the early clinical stages of AD. Apolipoprotein E4(APOE4), the major AD susceptibility gene, leads to accelerated blood-brain barrier breakdown & degeneration of brain capillary pericyte that maintain blood-brain barrier integrity.

View Article and Find Full Text PDF

Background: Aging and the decline in sex steroid hormone (e.g., estrogen) are associated with a potential loss of its neuroprotective effects on the female brain.

View Article and Find Full Text PDF

Alzheimer's Imaging Consortium.

Alzheimers Dement

December 2024

Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Background: Cerebral small vessel disease (CSVD), which includes cerebral amyloid angiopathy (CAA) and arteriolosclerosis, often co-occurs with Alzheimer's disease (AD) pathology. The medial temporal lobe (MTL) is susceptible to hosting multiple AD pathologies, such as neurofibrillary tangles (NFTs), amyloid-ß plaques, phospho-Tar-DNA-Binding-Protein-43 (pTDP-43), as well as CSVD. Whether a causal relationship between these pathologies exists remains largely unknown, but one potential linking mechanism is the dysfunction of perivascular clearance.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!